Opportunities in Structured Cabling Systems $4,688.25 (€3,731.61) Publication Date: June 2010
Pages: 81
Publisher: FTM Consulting
Table of Contents
"Opportunities in Structured Cabling Systems" provides detailed analysis of future opportunities for suppliers to the structured cabling systems (SCS) market. This includes new product, new technology and new market opportunities for both the UTP and fiber cabling systems providers. The report provides quantitative data for the largest markets and highest growth markets for both the copper and fiber cable suppliers.
find out more | | Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects $1,780.13 (€1,416.89) Published: July 2010
Format: PDF
Pages: 183
Report Table of Contents [Downloadable PDF File] Sample Pages from the Market Report [Downloadable PDF File] This innovative & analytical report can be used to assess market trends & appraise the potential of new antibodies & therapeutic proteins. It provides perspective to: - gain an in-depth understanding of the marketplace, players, products & leading technologies driving the field;
- evaluate the unmet clinical needs, product pipelines & technological challenges for the next generation of mAbs & TPs;
- identify the key regulatory, IP & reimbursement issues which face biopharmaceutical companies;
- assess the therapeutic potential of new mAbs & TPs targeting cancer, immuno-inflammatory related disorders, CNS disorders & others;
- identify the potential threat of biosimilars & examine their impact on the prescription & development of new biologics now & in the future;
- analyze the market trends & highlight future market opportunities.
find out more | | Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014)
Publication Date: 21-Jul-2010
Format: pdf
Pages: 272
Publisher: MarketsandMarkets
Table of Contents
Bioinformatics has gained high importance due to its ability to facilitate rapid clinical research, and also due to its various applications such as gene therapy and molecular science. Bioinformatics uses information technology, statistics, and algorithms to integrate biological data. Pharmaceutical companies are now adopting automated technologies to manufacture effective therapies and drugs due to increasing concerns about drug safety and the stringent regulations that govern clinical trials for drug discovery. Pharmaceutical companies have increased their focus on process improvement and quality, as the current competitive scenario offers little scope for price escalation and product differentiation.
find out more |
